Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 11, 2011BMC Research NotesOpen Access

Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJan LarsenUniversity of CopenhagenOPOlof PetterssonUppsala UniversityMJMaria JakobsenAarhus University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Larsen et al. (2011) studied this question.

synapsesocial.com/papers/6a98be1fd2b4da1de4bd3e1dhttps://doi.org/10.1186/1756-0500-4-490
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons2004 · 537 citations
  2. 2Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts1997 · 476 citations
  3. 3HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 12010 · 20 citations
  4. 4Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy2005 · 244 citations
  5. 5Pathogenic mechanisms of myotonic dystrophy2009 · 303 citations